Recombinant Factor XIII (rFXIII)

Factor XIII, recombinant · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Recombinant Factor XIII (rFXIII), covering 2014-06-18 to 2016-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency [Phase 3]

See pricing